Associated Papers
Plasma cell-free tumor DNA, PIK3CA and TP53 mutations predicted inferior endocrine-based treatment outcome in endocrine receptor-positive metastatic breast cancer.
Chen TW et al.
Breast Cancer Research and Treatment, 2023
[PIK3CA gene mutations in Chinese women with HR+/HER2- breast cancer].
Wu SF et al.
Zhonghua Bing Li Xue Za Zhi = Chinese Journal of Pathology, 2022
Integrative omics analyses broaden treatment targets in human cancer.
Sengupta S et al.
Genome Medicine, 2018
30053901 (PubMed )
Supplement: 13073_2018_564_MOESM2_ESM.xlsx › 13
Sporadic Early-Onset Diffuse Gastric Cancers Have High Frequency of Somatic CDH1 Alterations, but Low Frequency of Somatic RHOA Mutations Compared With Late-Onset Cancers.
Cho SY et al.
Gastroenterology, 2017
28522256 (PubMed )
Supplement: NIHMS1058936-supplement-Table_S3.xlsx › VCF
Heterogeneity of PIK3CA mutational status at the single cell level in circulating tumor cells from metastatic breast cancer patients.
Pestrin M et al.
Molecular Oncology, 2015
Select a paper to view details